Literature DB >> 15997444

Biopsy of resectable colorectal liver metastases causes tumour dissemination and adversely affects survival after liver resection.

O M Jones1, M Rees, T G John, S Bygrave, G Plant.   

Abstract

BACKGROUND: Liver resection is increasingly being performed for metastatic colorectal cancer. This study assessed the need for preoperative biopsy of suspected metastases and whether biopsy has any effect on long-term survival.
METHODS: Prospectively collected data on patients who underwent liver resection for colorectal metastases between 1986 and 2003 were reviewed retrospectively. The endpoints of morbidity, operative mortality and long-term survival were compared between patients who had biopsy before referral (group 1) and those who did not (group 2).
RESULTS: Patient demographics and disease distribution were similar for 90 patients in group 1 and 508 in group 2. Seventeen patients (19 per cent) who had undergone biopsy either at the time of colorectal resection or radiologically had evidence of needle-track deposits. Operative mortality and morbidity rates in the two groups were similar. The 4-year survival rate after liver resection was 32.5 (s.e. 5.5) per cent in group 1, compared with 46.7 (2.8) per cent in group 2 (P = 0.008).
CONCLUSION: Needle-track deposits are common after biopsy of suspected colorectal liver metastases. Biopsy of metastases confers poorer long-term survival on patients after liver resection and cannot be justified in patients with potentially resectable disease. Copyright 2005 British Journal of Surgery Society Ltd.

Entities:  

Mesh:

Year:  2005        PMID: 15997444     DOI: 10.1002/bjs.4888

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  30 in total

Review 1.  Current treatment for colorectal liver metastases.

Authors:  Evangelos P Misiakos; Nikolaos P Karidis; Gregory Kouraklis
Journal:  World J Gastroenterol       Date:  2011-09-28       Impact factor: 5.742

2.  Contrast-enhanced intraoperative ultrasound improves detection of liver metastases during surgery for primary colorectal cancer.

Authors:  Ankur J Shah; Mark Callaway; Michael G Thomas; Meg D Finch-Jones
Journal:  HPB (Oxford)       Date:  2010-04       Impact factor: 3.647

3.  Biopsy of potentially operable hepatic colorectal metastases is not useless but dangerous.

Authors:  Oliver M Jones; Myrddin Rees; Tim G John; Sean Bygrave; Graham Plant
Journal:  BMJ       Date:  2004-10-30

4.  Guidelines for resection of colorectal cancer liver metastases.

Authors:  O J Garden; M Rees; G J Poston; D Mirza; M Saunders; J Ledermann; J N Primrose; R W Parks
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

5.  Late gadolinium MRI enhancement of colorectal liver metastases is associated with overall survival among nonsurgical patients.

Authors:  Helen M C Cheung; Jin K Kim; John Hudson; Natalie Coburn; Paul J Karanicolas; Calvin Law; Laurent Milot
Journal:  Eur Radiol       Date:  2019-04-01       Impact factor: 5.315

Review 6.  How does genome sequencing impact surgery?

Authors:  Marlies S Reimers; Charla C Engels; Peter J K Kuppen; Cornelis J H van de Velde; Gerrit J Liefers
Journal:  Nat Rev Clin Oncol       Date:  2014-06-24       Impact factor: 66.675

Review 7.  Chinese guidelines for the diagnosis and comprehensive treatment of hepatic metastasis of colorectal cancer.

Authors:  Jianmin Xu; Xinyu Qin; Jianping Wang; Suzhan Zhang; Yunshi Zhong; Li Ren; Ye Wei; Shaochong Zeng; Deseng Wan; Shu Zheng
Journal:  J Cancer Res Clin Oncol       Date:  2011-07-28       Impact factor: 4.553

8.  Usefulness of cutting needle biopsy in recurrent and advanced staged head and neck malignancies in a palliative setting.

Authors:  G J Ridder; J Pfeiffer
Journal:  Support Care Cancer       Date:  2007-03-21       Impact factor: 3.603

9.  Prevention of tumour cell dissemination in diagnostic needle procedures.

Authors:  H Wiksell; K-U Schässburger; M Janicijevic; K Leifland; L Löfgren; S Rotstein; P-O Sandberg; C Wadström; G Auer
Journal:  Br J Cancer       Date:  2010-11-02       Impact factor: 7.640

10.  Long-term follow-up in 54 surgically treated patients with gastrointestinal stromal tumours.

Authors:  Konrad Klaus Richter; Constanze Schmid; Mark Thompson-Fawcett; Utz Settmacher; Annelore Altendorf-Hofmann
Journal:  Langenbecks Arch Surg       Date:  2008-03-13       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.